Metabolic Syndrome and the Risk of Kidney Stones: Evidence from 487 860 UK Biobank Participants
The Journal of Clinical Endocrinology & Metabolism · 2025
DOI: 10.1210/clinem/dgae295 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2025. Verfasst von Minghui Liu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China. Hauptthemen laut MEDLINE: Metabolic Syndrome, Kidney Calculi. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 44 Literaturangaben. Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Context
While some studies have suggested an association between metabolic syndrome and kidney stones, the quality and level of evidence in these studies vary.
Objective
Whether some individual characteristics and clustering of metabolic syndrome traits increase the risk of kidney stones has not been examined in a large-scale prospective cohort. Materials We conducted a retrospective analysis of data from a prospective cohort of 487 860 UK Biobank participants who were free from kidney stones at baseline. The presence of metabolic syndrome was based on 5 criteria: abdominal obesity, high triglyceride levels, low high-density lipoprotein (HDL) cholesterol levels, high blood pressure (HBP), and type 2 diabetes mellitus (T2DM). Cox proportional hazards regression models were used to evaluate the association between metabolic syndrome and risk of kidney stones.
Results
After an average follow-up period of 12.6 years, a total of 5213 of the 487 860 participants included in the UK Biobank study developed kidney stones. The partial traits of metabolic syndrome, including waist circumference (hazard ratio [HR]: 1.15; 95% CI, 1.10-1.20), HDL cholesterol (0.66; 95% CI, 0.55-0.79), HBP (1.11; 95% CI, 1.03-1.19), and T2DM (1.14; 95% CI, 1.04-1.21), were independently associated with the occurrence of kidney stones. The clustering of metabolic syndrome is significantly associated with kidney stone formation, and as the number of metabolic syndrome traits increases, the risk of kidney stones gradually increases.
Conclusion
Metabolic syndrome is a significant and independent risk factor for the development of kidney stones. This association suggests that kidney stones may represent a systemic disorder influenced by the interplay of various metabolic risk factors.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Urology, Xiangya Hospital, Central South University, Changsha, 410008, China.
- National Clinical Research Center for Geriatric Disorders, Xiangya Hospital, Central South University, Changsha, 410008, China.
- Department of Internal Medicine, Section Endocrinology, Yale University School of Medicine, New Haven, CT 06510, USA.
ORCID-Profile: Zhiyong Chen, Jinbo Chen
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Liu, M., Gao, M., Wu, J., Zhu, Z., Hu, J., Chen, H., Chen, Z., & Chen, J. (2025). Metabolic Syndrome and the Risk of Kidney Stones: Evidence from 487 860 UK Biobank Participants. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgae295
Vancouver
Liu M, Gao M, Wu J, Zhu Z, Hu J, Chen H, et al. Metabolic Syndrome and the Risk of Kidney Stones: Evidence from 487 860 UK Biobank Participants. The Journal of Clinical Endocrinology & Metabolism. 2025. doi:10.1210/clinem/dgae295
BibTeX
@article{Liu2025,
author = {Liu, Minghui and Gao, Meng and Wu, Jian and Zhu, Zewu and Hu, Jiao and Chen, Hequn and Chen, Zhiyong and Chen, Jinbo},
title = {Metabolic Syndrome and the Risk of Kidney Stones: Evidence from 487 860 UK Biobank Participants},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2025},
doi = {10.1210/clinem/dgae295}
}
EUVIMED